{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T04:44:52Z","timestamp":1778561092326,"version":"3.51.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-02541-z","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:32:03Z","timestamp":1747096323000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Causal links between plasma lipidome and ovarian cancer risk: evidence from Mendelian randomization"],"prefix":"10.1007","volume":"16","author":[{"given":"Huke","family":"Dong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,13]]},"reference":[{"key":"2541_CR1","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3322\/caac.21456","volume":"68","author":"LA Torre","year":"2018","unstructured":"Torre LA, Trabert B, DeSantis CE, Miller KD, Samimi G, Runowicz CD, et al. Ovarian cancer statistics, 2018. CA Cancer J Clin. 2018;68:284\u201396.","journal-title":"CA Cancer J Clin"},{"key":"2541_CR2","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1097\/CM9.0000000000002108","volume":"135","author":"C Xia","year":"2022","unstructured":"Xia C, Dong X, Li H, Cao M, Sun D, He S, et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants. Chin Med J (Engl). 2022;135:584\u201390.","journal-title":"Chin Med J (Engl)"},{"key":"2541_CR3","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.soncn.2019.02.001","volume":"35","author":"C Stewart","year":"2019","unstructured":"Stewart C, Ralyea C, Lockwood S. Ovarian cancer: an integrated review. Semin Oncol Nurs. 2019;35:151\u20136.","journal-title":"Semin Oncol Nurs"},{"key":"2541_CR4","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1158\/0008-5472.CAN-15-2613","volume":"76","author":"OF Kuzu","year":"2016","unstructured":"Kuzu OF, Noory MA, Robertson GP. The role of cholesterol in cancer. Cancer Res. 2016;76:2063\u201370.","journal-title":"Cancer Res"},{"key":"2541_CR5","first-page":"219","volume":"9","author":"X Ding","year":"2019","unstructured":"Ding X, Zhang W, Li S, Yang H. The role of cholesterol metabolism in cancer. Am J Cancer Res. 2019;9:219\u201327.","journal-title":"Am J Cancer Res"},{"key":"2541_CR6","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3389\/fphar.2013.00119","volume":"4","author":"PM Cruz","year":"2013","unstructured":"Cruz PM, Mo H, McConathy WJ, Sabnis N, Lacko AG. The role of cholesterol metabolism and cholesterol transport in carcinogenesis: a review of scientific findings, relevant to future cancer therapeutics. Front Pharmacol. 2013;4:119.","journal-title":"Front Pharmacol"},{"key":"2541_CR7","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s00404-024-07537-8","volume":"310","author":"G Levin","year":"2024","unstructured":"Levin G, Brezinov Y, Tzur Y, Bar-Noy T, Brodeur MN, Salvador S, et al. Association between BMI and oncologic outcomes in epithelial ovarian cancer: a predictors-matched case-control study. Arch Gynecol Obstet. 2024;310:587\u201393.","journal-title":"Arch Gynecol Obstet"},{"key":"2541_CR8","doi-asserted-by":"publisher","first-page":"153303382412776","DOI":"10.1177\/15330338241277699","volume":"23","author":"XY Jiang","year":"2024","unstructured":"Jiang XY, Zheng L, Xiong M, Wang SL, Jin QQ, Yang YT, et al. Body mass index and risk of female reproductive system tumors subtypes: a meta-analysis using mendelian randomization. Technol Cancer Res Treat. 2024;23:15330338241277700.","journal-title":"Technol Cancer Res Treat"},{"key":"2541_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbpa.2023.102370","volume":"76","author":"S Salihovic","year":"2023","unstructured":"Salihovic S, Lamichane S, Hy\u00f6tyl\u00e4inen T, Ore\u0161i\u010d M. Recent advances towards mass spectrometry-based clinical lipidomics. Curr Opin Chem Biol. 2023;76: 102370.","journal-title":"Curr Opin Chem Biol"},{"key":"2541_CR10","doi-asserted-by":"publisher","first-page":"4913","DOI":"10.1093\/eurheartj\/ehad736","volume":"44","author":"SC Larsson","year":"2023","unstructured":"Larsson SC, Butterworth AS, Burgess S. Mendelian randomization for cardiovascular diseases: principles and applications. Eur Heart J. 2023;44:4913\u201324.","journal-title":"Eur Heart J"},{"key":"2541_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n2233","volume":"375","author":"VW Skrivankova","year":"2021","unstructured":"Skrivankova VW, Richmond RC, Woolf BAR, Davies NM, Swanson SA, VanderWeele TJ, et al. Strengthening the reporting of observational studies in epidemiology using mendelian randomisation (STROBE-MR): explanation and elaboration. BMJ. 2021;375: n2233.","journal-title":"BMJ"},{"key":"2541_CR12","doi-asserted-by":"publisher","first-page":"6934","DOI":"10.1038\/s41467-023-42532-8","volume":"14","author":"L Ottensmann","year":"2023","unstructured":"Ottensmann L, Tabassum R, Ruotsalainen SE, Gerl MJ, Klose C, Wid\u00e9n E, et al. Genome-wide association analysis of plasma lipidome identifies 495 genetic associations. Nat Commun. 2023;14:6934.","journal-title":"Nat Commun"},{"key":"2541_CR13","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s12876-024-03246-3","volume":"24","author":"J Zhou","year":"2024","unstructured":"Zhou J, Zhu D, Xu Y, Chen C, Wang K. Genetically predicted gut microbiota mediate the association between plasma lipidomics and primary sclerosing cholangitis. BMC Gastroenterol. 2024;24:158.","journal-title":"BMC Gastroenterol"},{"key":"2541_CR14","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.0034","volume":"6","author":"B Rayes","year":"2023","unstructured":"Rayes B, Ardissino M, Slob EAW, Patel KHK, Girling J, Ng FS. Association of hypertensive disorders of pregnancy with future cardiovascular disease. JAMA Netw Open. 2023;6: e230034.","journal-title":"JAMA Netw Open"},{"key":"2541_CR15","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","volume":"50","author":"M Verbanck","year":"2018","unstructured":"Verbanck M, Chen CY, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet. 2018;50:693\u20138.","journal-title":"Nat Genet"},{"key":"2541_CR16","doi-asserted-by":"publisher","first-page":"18156","DOI":"10.1038\/s41598-021-97433-x","volume":"11","author":"MF Buas","year":"2021","unstructured":"Buas MF, Drescher CW, Urban N, Li CI, Bettcher L, Hait NC, et al. Quantitative global lipidomics analysis of patients with ovarian cancer versus benign adnexal mass. Sci Rep. 2021;11:18156.","journal-title":"Sci Rep"},{"key":"2541_CR17","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1093\/ije\/dyr130","volume":"40","author":"T Bj\u00f8rge","year":"2011","unstructured":"Bj\u00f8rge T, Lukanova A, Tretli S, Manjer J, Ulmer H, Stocks T, et al. Metabolic risk factors and ovarian cancer in the Metabolic Syndrome and Cancer project. Int J Epidemiol. 2011;40:1667\u201377.","journal-title":"Int J Epidemiol"},{"key":"2541_CR18","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s10654-021-00757-1","volume":"36","author":"AR Carter","year":"2021","unstructured":"Carter AR, Sanderson E, Hammerton G, Richmond RC, Davey Smith G, Heron J, et al. Mendelian randomisation for mediation analysis: current methods and challenges for implementation. Eur J Epidemiol. 2021;36:465\u201378.","journal-title":"Eur J Epidemiol"},{"key":"2541_CR19","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s10654-015-0011-z","volume":"30","author":"S Burgess","year":"2015","unstructured":"Burgess S, Scott RA, Timpson NJ, Davey Smith G, Thompson SG. Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors. Eur J Epidemiol. 2015;30:543\u201352.","journal-title":"Eur J Epidemiol"},{"key":"2541_CR20","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41467-019-13870-3","volume":"11","author":"V Zuber","year":"2020","unstructured":"Zuber V, Colijn JM, Klaver C, Burgess S. Selecting likely causal risk factors from high-throughput experiments using multivariable Mendelian randomization. Nat Commun. 2020;11:29.","journal-title":"Nat Commun"},{"key":"2541_CR21","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646\u201374.","journal-title":"Cell"},{"key":"2541_CR22","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.ccr.2012.02.014","volume":"21","author":"PS Ward","year":"2012","unstructured":"Ward PS, Thompson CB. Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. Cancer Cell. 2012;21:297\u2013308.","journal-title":"Cancer Cell"},{"key":"2541_CR23","doi-asserted-by":"publisher","first-page":"7742","DOI":"10.3390\/ijms14047742","volume":"14","author":"CE Pyragius","year":"2013","unstructured":"Pyragius CE, Fuller M, Ricciardelli C, Oehler MK. Aberrant lipid metabolism: an emerging diagnostic and therapeutic target in ovarian cancer. Int J Mol Sci. 2013;14:7742\u201356.","journal-title":"Int J Mol Sci"},{"key":"2541_CR24","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3747\/co.v17i5.668","volume":"17","author":"M Tania","year":"2010","unstructured":"Tania M, Khan MA, Song Y. Association of lipid metabolism with ovarian cancer. Curr Oncol. 2010;17:6\u201311.","journal-title":"Curr Oncol"},{"key":"2541_CR25","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1093\/jnci\/88.1.32","volume":"88","author":"KJ Helzlsouer","year":"1996","unstructured":"Helzlsouer KJ, Alberg AJ, Norkus EP, Morris JS, Hoffman SC, Comstock GW. Prospective study of serum micronutrients and ovarian cancer. J Natl Cancer Inst. 1996;88:32\u20137.","journal-title":"J Natl Cancer Inst"},{"key":"2541_CR26","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1146\/annurev-physiol-020518-114444","volume":"81","author":"B Wang","year":"2019","unstructured":"Wang B, Tontonoz P. Phospholipid remodeling in physiology and disease. Annu Rev Physiol. 2019;81:165\u201388.","journal-title":"Annu Rev Physiol"},{"key":"2541_CR27","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/nrm.2017.138","volume":"19","author":"T Harayama","year":"2018","unstructured":"Harayama T, Riezman H. Understanding the diversity of membrane lipid composition. Nat Rev Mol Cell Biol. 2018;19:281\u201396.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2541_CR28","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1111\/febs.14281","volume":"285","author":"U Ray","year":"2018","unstructured":"Ray U, Roy SS. Aberrant lipid metabolism in cancer cells - the role of oncolipid-activated signaling. Febs j. 2018;285:432\u201343.","journal-title":"Febs j"},{"key":"2541_CR29","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1002\/jcb.24539","volume":"114","author":"HY Lin","year":"2013","unstructured":"Lin HY, Delmas D, Vang O, Hsieh TC, Lin S, Cheng GY, et al. Mechanisms of ceramide-induced COX-2-dependent apoptosis in human ovarian cancer OVCAR-3 cells partially overlapped with resveratrol. J Cell Biochem. 2013;114:1940\u201354.","journal-title":"J Cell Biochem"},{"key":"2541_CR30","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1038\/80442","volume":"6","author":"Y Morita","year":"2000","unstructured":"Morita Y, Perez GI, Paris F, Miranda SR, Ehleiter D, Haimovitz-Friedman A, et al. Oocyte apoptosis is suppressed by disruption of the acid sphingomyelinase gene or by sphingosine-1-phosphate therapy. Nat Med. 2000;6:1109\u201314.","journal-title":"Nat Med"},{"key":"2541_CR31","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.1038\/onc.2015.330","volume":"35","author":"K Kitatani","year":"2016","unstructured":"Kitatani K, Usui T, Sriraman SK, Toyoshima M, Ishibashi M, Shigeta S, et al. Ceramide limits phosphatidylinositol-3-kinase C2\u03b2-controlled cell motility in ovarian cancer: potential of ceramide as a metastasis-suppressor lipid. Oncogene. 2016;35:2801\u201312.","journal-title":"Oncogene"},{"key":"2541_CR32","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/nrc1411","volume":"4","author":"B Ogretmen","year":"2004","unstructured":"Ogretmen B, Hannun YA. Biologically active sphingolipids in cancer pathogenesis and treatment. Nat Rev Cancer. 2004;4:604\u201316.","journal-title":"Nat Rev Cancer"},{"key":"2541_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0019963","volume":"6","author":"MY Fong","year":"2011","unstructured":"Fong MY, McDunn J, Kakar SS. Identification of metabolites in the normal ovary and their transformation in primary and metastatic ovarian cancer. PLoS ONE. 2011;6: e19963.","journal-title":"PLoS ONE"},{"key":"2541_CR34","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1093\/jnci\/djz195","volume":"112","author":"OA Zeleznik","year":"2020","unstructured":"Zeleznik OA, Clish CB, Kraft P, Avila-Pacheco J, Eliassen AH, Tworoger SS. Circulating lysophosphatidylcholines, phosphatidylcholines, ceramides, and sphingomyelins and ovarian cancer risk: a 23-year prospective study. J Natl Cancer Inst. 2020;112:628\u201336.","journal-title":"J Natl Cancer Inst"},{"key":"2541_CR35","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s13048-021-00911-z","volume":"14","author":"K Tanha","year":"2021","unstructured":"Tanha K, Mottaghi A, Nojomi M, Moradi M, Rajabzadeh R, Lotfi S, et al. Investigation on factors associated with ovarian cancer: an umbrella review of systematic review and meta-analyses. J Ovarian Res. 2021;14:153.","journal-title":"J Ovarian Res"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-02541-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-02541-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-02541-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T13:06:36Z","timestamp":1747227996000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-02541-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,13]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2541"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-02541-z","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,13]]},"assertion":[{"value":"22 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"745"}}